Gerontology Committee. Clinical therapeutic approach to older adults with diabetes mellitus

Authors

  • Ana Lía Cagide Dr. Gutman Endocrinology and Diabetes Center, Autonomous City of Buenos Aires, Argentina
  • Isabel Cavani University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina
  • Teresa Cavani University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina
  • Héctor Cutuli Bocalandro Hospital, Province of Buenos Aires, Argentina
  • Paola Finocchietto University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina
  • Mónica González Hospital of the Province of Corrientes, Corrientes, Argentina
  • Mario Pisarenco Estancia del Sol Residence for Older Adults, Province of Buenos Aires, Argentina
  • Lucía Poggio National Program for Prevention and Control of Diabetes, Autonomous City of Buenos Aires, Argentina
  • Haydee Rodríguez Private office, Quilmes, Province of Buenos Aires, Argentina
  • Gustavo Tomás Díaz Gerevini National University of Córdoba (UNC) , Researcher at the Institute of Cellular Biology (UNC), Córdoba, Argentina

DOI:

https://doi.org/10.47196/diab.v58i1Sup.762

Keywords:

older adult, health equipment, therapeutic approach

Abstract

The development of civilization is associated with an increase in the age of the population. Today in Argentina, the elderly man (AM: person aged 65 years or older) has a life expectancy of 76 years and women 80 years, which represents 15% of the percentage of the population in large urban centers. It is estimated that the percentage of MA with diabetes mellitus (DM) is between 20-30%. This pathology, its comorbidities and complications (especially cardiovascular, infectious, cognitive and oncological) call for an effort from the health team and, especially, from people dedicated to this age group.

A multidisciplinary approach is important, adapted to the circumstances of the person and their sociocultural and economic situation, guiding primary, secondary and tertiary prevention resources.

In the face of constant change, the participation of the health team is currently required to provide answers to solutions where metabolic, cardiovascular, cognitive and mobility control tend to maintain the functional independence of the person in order to prioritize the safety of diagnostic techniques. and therapeutics in a framework of dialogue and agreements.

Author Biographies

Ana Lía Cagide, Dr. Gutman Endocrinology and Diabetes Center, Autonomous City of Buenos Aires, Argentina

Medical specialist in Endocrinology and specialized in Diabetes

Isabel Cavani, University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina

Professor, Medical Specialist in Diabetes, Director of the Department of Teaching and Research, Sirio Libanés Hospital, Professor of the Faculty of Medical Sciences

Teresa Cavani, University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina

Endocrinologist Medical Professor, Diabetes Service, British Hospital, Professor at the Faculty of Medical Sciences

Héctor Cutuli, Bocalandro Hospital, Province of Buenos Aires, Argentina

Medical specialist in Nutrition and Diabetes, Head of the Medical Clinic Service

Paola Finocchietto, University of Buenos Aires (UBA), Autonomous City of Buenos Aires, Argentina

Prof. Doctor of Medicine, specialist in Internal Medicine and specialized in Diabetes, Hospital de Clínicas Gral. José de San Martín, Medicus Diabetes Service, Professor at the Faculty of Medical Sciences

Mónica González, Hospital of the Province of Corrientes, Corrientes, Argentina

Doctor specialized in Medical Clinic, Geriatrics and Diabetes, Director of the Hospital of the Province of Corrientes

Mario Pisarenco, Estancia del Sol Residence for Older Adults, Province of Buenos Aires, Argentina

Doctor specialized in Medical Clinic, Geriatrics and Diabetes, Director of the Estancia del Sol Residence for Older Adults

Lucía Poggio, National Program for Prevention and Control of Diabetes, Autonomous City of Buenos Aires, Argentina

Medical consultant expert in Diabetes, Ministry of Health of the Nation

Haydee Rodríguez, Private office, Quilmes, Province of Buenos Aires, Argentina

Doctor specialized in Medical Clinic, Diabetes and Geriatrics

Gustavo Tomás Díaz Gerevini, National University of Córdoba (UNC) , Researcher at the Institute of Cellular Biology (UNC), Córdoba, Argentina

Prof. Doctor of Medicine, specialist in Geriatrics, Family Medicine and expert in Diabetes, Master in Gerontology, Coordinator of the Gerontology Committee, Argentine Diabetes Society (SAD), Professor of the Faculty of Medical Sciences

References

I. Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas 2020;139:6-11.

II. Bautmans I, Knoop V, Amuthavalli-Thiyagarajan J, Maier AB, Beard JR, Freiberger E, Belsky D, Aubertin-Leheudre M, Mikton C, Cesari M, Sumi Y, Diaz T, Banerjee A; WHO Working Group on Vitality Capacity. WHO working definition of vitality capacity for healthy longevity monitoring. Lancet Healthy Longev 2022 ;3(11):e789-e796.

III. Censo República Argentina 2022. Disponible en: https://censo.gob.ar.

IV. Akhter S. Low to no cost remedies for the management of diabetes mellitus; global health concern. J Diabetes Metab Disord 2021;20(1):951-962.

V. Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 2022;18(9):525-539.

VI. Munshi MN, Meneilly GS, Rodríguez-Mañas L, Close KL, Conlin PR, Cukierman-Yaffe T, Forbes A, Ganda OP, Kahn CR, Huang E, Laffel LM, Lee CG, Lee S, Nathan DM, Pandya N, Pratley R, Gabbay R, Sinclair AJ. Diabetes in ageing: pathways for developing the evidence base for clinical guidance. Lancet Diabetes Endocrinol 2020;8(10):855-867.

VII. American Diabetes Association Professional Practice Committee. Older adults: Standards of Care in Diabetes 2024.Diabetes Care 2024;47 (Supp1):S244-S257.

VIII. Doucet J, Gourdy P, Meyer L, Benabdelmoumene N, Bourdel-Marchasson I. Management of glucose-lowering therapy in older adults with type 2 diabetes: challenges and opportunities. Clin Interv Aging 2023;18:1687-1703.

IX. Cuarta Encuesta Nacional de Factores de Riesgo. Resultados definitivos. Octubre de 2019. Instituto Nacional de Estadística y Censos (INDEC). Secretaría de Gobierno de Salud de la Nación. Disponible en: https://www.indec.gob.ar/ftp/cuadros/publicaciones/enfr_2018_resultados_definitivos.pdf.

X. LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ. Treatment of diabetes in older adults. An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2019;104(5):1520-1574.

XI. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: developing a diabetes mellitus comprehensive care plan-2022 update. Endocr Pract 2022;28(10):923-1049.

XII. Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S; RSSDI-ESI Consensus Group. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. Indian J Endocrinol Metab 2020 ;24(1):1-122.

XIII. Díaz-Gerevini GT, Iglesias-Marichal I, Avila MB, Reartes G, et al. Adulto mayor con diabetes. Recomendaciones para el equipo de salud en el abordaje del adulto mayor. Ed. Académica Española. República de Moldavia;2021.

XIV. Morris RL, Giles S, Campbell S. Involving patients and carers in patient safety in primary care. A qualitative study of a co-designed patient safety guide. Health Expect. 2023;26 (2):630-639.

XV. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006;35(5):526-9.

XVI. Bandeen-Roche K, Seplaki CL, Huang J, et al. Frailty in older adults: a nationally representative profile in the United States. J Gerontol A Biol Sci Med Sci 2015;70:1427–1434.

XVII. Díaz-Gerevini GT, Repossi G, Dain A, Das UN, Eynard AR. Cognitive and motor perturbations in elderly longstanding subjects with diabetes mellitus. Nutrition 2014; 30:628-35.

XVIII. Díaz G, Repossi G, Szafryk de Mereshian P. Encefalopatía diabética de la biología celular a la clínica (bases fisiopatológicas y propuestas terapéuticas no farmacológicas). Editorial de la Universidad Nacional de Córdoba, Argentina; 2021.

XIX. Kim MJ, Fritschi C. Relationships between cognitive impairment and self-management in older adults with type 2 diabetes. An integrative review. Res Gerontol Nurs 2021;14(2):104-112.

XX. Folstein M, Folstein SE, McHugh PR. “Mini-mental state” a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-198.

XXI. Gadisa DA, Gebremariam ET, Yimer G, Deresa Urgesa E. Attitudes of older adult patients and caregivers towards deprescribing of medications in Ethiopia. Clin Interv Aging 2023;18:1129-1143.

XXII. Markle-Reid M, Ploeg J, Fraser KD, Fisher KA, Akhtar-Danesh N, et al. The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial. Trials 2017;18(1):55.

XXIII. Cagide AL, Méndez J, Costa L, De Feo H, González M, et al. Aspectos clínicos y terapéuticos en adultos mayores con diabetes atendidos por médicos con formación diabetológica. Resúmenes del XV Congreso de la Asociación Latinoamericana de Diabetes. Cancún, México. Noviembre 2013.

XXIV. Brands MR, Gouw SC, Beestrum M, Cronin RM, Fijnvandraat K, Badawy SM. Patient-centered digital health records and their effects on health outcomes: systematic review. J Med Internet Res 2022;24(12):e43086.

XXV. Makam AN, Nguyen OK. An evidence-based medicine approach to antihyperglycemic therapy in diabetes mellitus to overcome overtreatment. Circulation 2017;135 (2):180-195.

XXVI. Doni K, Bühn S, Weise A, Mann NK, Hess S, Sönnichsen A, Pieper D, Thürmann P, Mathes T. Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Drug Saf 2022 Jan 21;13:20420986211072383.

XXVII. Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab 2019;30:72-130.

XXVIII. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetol 2022;65(12):1925-1966.

XXIX. Trombara F, Cosentino N, Bonomi A, Ludergnani M, Poggio P, Gionti L, Baviera M, Colacioppo P, Roncaglioni MC, Leoni O, Bortolan F, Agostoni P, Genovese S, Marenzi G. Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction. Cardiovasc Diabetol 2023;22 (1):26.

XXX. Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J. How many patients with type 2 diabetes meet the inclusion criteria of the cardiovascular outcome trials with SGLT2 inhibitors? Estimations from a population database in a Mediterranean Area. J Diabetes Res 2019;2019:2018374.

XXXI. Abdelmasih R, Abdelmaseih R, Thakker R, Faluk M, Ali A, Alsamman MM, Hasan SM. Update on the cardiovascular benefits of sodium-glucose co-transporter-2 inhibitors: mechanism of action, available agents and comprehensive review of literature. Cardiol Res 2021;12(4):210-218.

XXXII. Song J, Li X, Ni J. A Role for sodium-glucose cotransporter 2 inhibitors in the treatment of chronic kidney disease. A mini review. Kidney Blood Press Res 2023;48(1):599-610.

XXXIII. Hermann M, Heimro LS, Haugstvedt A, Hernar I, Sigurdardottir AK, Graue M. Hypoglycaemia in older home-dwelling people with diabetes- a scoping review. BMC Geriatr 2021;21(1):20.

XXXIV. Lee AK, Lee CJ, Huang ES, Sharrett AR, Coresh J, Selvin E. Risk factors for severe hypoglycemia in black and white adults with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2017;40:1661-1667.

XXXV. Cheng AYY, Wong J, Freemantle N, Acharya SH, Ekinci E. The safety and efficacy of second-generation basal insulin analogues in adults with type 2 diabetes at risk of hypoglycemia and use in other special populations. A narrative review. Diabetes Ther 2020;11(11):2555-2593.

XXXVI. Neumann-Podczaska A, Tobis S, Antimisiaris D, Mossakowska M, Puzianowska-Kuznicka M, Chudek J, Wierucki L, Merks P, Wizner B, Sobieszczanska M, Niemir ZI, Kaczmarek B, Wieczorowska-Tobis K. Polypharmacy in Polish older adult population. A cross-sectional study. Results of the PolSenior Project. Int J Environ Res Public Health 2022;19(3):1030.

XXXVII. Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edelman SV, Morello CM. Estimated cost-effectiveness, cost denefit, and risk reduction associated with an endocrinologist-pharmacist diabetes intense medical management "tune-uUp" Clinic J Manag Care Spec Pharm 2017;23(3):318-326.

XXXVIII. Tamura Y, Omura T, Toyoshima K, Araki A. Nutrition management in older adults with diabetes. A review on the importance of shifting prevention strategies from metabolic syndrome to frailty. Nutrients 2020;12(11):3367.

XXXIX. Madlala SS, Hill J, Kunneke E, Kengne AP, Peer N, Faber M. Dietary diversity and its association with nutritional status, cardiometabolic risk factors and food choices of adults at risk for type 2 diabetes mellitus in Cape Town, South Africa. Nutrients 2022;14(15):3191.

XL. Díaz Gerevini GT, Quiroga P, López C, Repossi G. Presentación del trabajo: Desarrollo de un programa de actividad física preventivo (Programa Harmony) en adultos mayores. Instituto de Biología Celular, FCM, UNC. Cátedra de Biología Celular, Histología y Embriología. Facultad de Ciencias Médicas UNC y la Fundación Grupo Amigos de los Diabéticos de Villa Carlos Paz. Jornada de Investigación Científica de la Facultad de Ciencias Médicas 19 de octubre 1917.

XLI. Chang CH, Kuo CP, Huang CN, Hwang SL, Liao WC, Lee MC. Habitual physical activity and diabetes control in young and older adults with type II diabetes. A longitudinal correlational study. Int J Environ Res Public Health 2021;18(3):1330.

XLII. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the Health, Aging, and Body Composition study. Diabetes 2006;55:1813-1818.

XLIII. Avilés-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes across the continent. Curr Diab Rep 2020;20(11):62.

XLIV. Cross AJ, Elliott RA, Petrie K, Kuruvilla L, George J. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev 2020;5(5):CD012419.

XLV. Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes 2013;11:138.

XLVI. Avilés-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes across the continent. Curr Diab Rep 2020;20(11):62

Revista de la Sociedad Argentina de Diabetes: Suplemento Recomendaciones de los Comités de Trabajo de la SAD

Downloads

Published

2024-04-01

How to Cite

Cagide, A. L., Cavani, I., Cavani, T., Cutuli, H., Finocchietto, P., González, M., Pisarenco, M., Poggio, L., Rodríguez, H., & Díaz Gerevini, G. T. (2024). Gerontology Committee. Clinical therapeutic approach to older adults with diabetes mellitus. Journal of the Argentine Society of Diabetes, 58(1Sup), 28–32. https://doi.org/10.47196/diab.v58i1Sup.762

Issue

Vol. 58 No. 1Sup (2024): January/April 2024

Section

Recommendations

License

Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Most read articles by the same author(s)